First-in-human ex-vivo validation of carbonic anhydrase IX-PET for high-risk renal cancer (CAT-VHL - PNRR-POC-2023-12377493).

Saved in:
Bibliographic Details
Title: First-in-human ex-vivo validation of carbonic anhydrase IX-PET for high-risk renal cancer (CAT-VHL - PNRR-POC-2023-12377493).
Authors: Larcher A; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.; VHL Program, IRCCS Ospedale San Raffaele, Milan, Italy., Gelardi F; Department of Nuclear Medicine, IRCCS Ospedale San Raffaele, Milan, Italy., Antunovic L; Department of Nuclear Medicine, IRCCS Ospedale San Raffaele, Milan, Italy., Savi A; Department of Nuclear Medicine, IRCCS Ospedale San Raffaele, Milan, Italy., Olivieri M; Department of Nuclear Medicine, IRCCS Ospedale San Raffaele, Milan, Italy., Rainone P; Department of Nuclear Medicine, IRCCS Ospedale San Raffaele, Milan, Italy.; Institute of Molecular Bioimaging and Physiology-IBFM, CNR, Segrate, Italy., Sollini M; Department of Nuclear Medicine, IRCCS Ospedale San Raffaele, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Moresco RM; Department of Nuclear Medicine, IRCCS Ospedale San Raffaele, Milan, Italy.; Institute of Molecular Bioimaging and Physiology-IBFM, CNR, Segrate, Italy.; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy., Re C; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.; VHL Program, IRCCS Ospedale San Raffaele, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Cei F; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.; VHL Program, IRCCS Ospedale San Raffaele, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Belladelli F; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.; VHL Program, IRCCS Ospedale San Raffaele, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Musso G; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.; VHL Program, IRCCS Ospedale San Raffaele, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Salerno L; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.; VHL Program, IRCCS Ospedale San Raffaele, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., De Cobelli F; Vita-Salute San Raffaele University, Milan, Italy.; Department of Radiology, IRCCS Ospedale San Raffaele, Milan, Italy., Tenace N; Vita-Salute San Raffaele University, Milan, Italy.; Department of Pathology, IRCCS Ospedale San Raffaele, Milan, Italy., Ponzoni M; Vita-Salute San Raffaele University, Milan, Italy.; Department of Pathology, IRCCS Ospedale San Raffaele, Milan, Italy., Cigliola A; Department of Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Verze P; Department of Urology, AOU San Giovanni di Dio Ruggi d'Aragona, Salerno, Italy.; Università degli Studi di Salerno, Salerno, Italy., Bertini R; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.; VHL Program, IRCCS Ospedale San Raffaele, Milan, Italy., Briganti A; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.; VHL Program, IRCCS Ospedale San Raffaele, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Montorsi F; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.; VHL Program, IRCCS Ospedale San Raffaele, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Capitanio U; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.; VHL Program, IRCCS Ospedale San Raffaele, Milan, Italy., Salonia A; Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.; VHL Program, IRCCS Ospedale San Raffaele, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Chiti A; Department of Nuclear Medicine, IRCCS Ospedale San Raffaele, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy.
Source: Theranostics [Theranostics] 2026 May 18; Vol. 16 (12), pp. 6980-6987. Date of Electronic Publication: 2026 May 18 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1838-7640
DOI:10.7150/thno.122256